Medigene AG (MDG1) — Capital Reinvestment Ratio
Medigene AG (MDG1) has a Capital Reinvestment Ratio of 0.01x as of June 2022, meaning it reinvests 0% of its operating cash flow (€17.30 Million) in capital expenditures (€230.00K). Check MDG1 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medigene AG Capital Reinvestment Ratio (2011–2022)
This chart tracks Medigene AG's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Medigene AG operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Medigene AG (2011–2022)
Year-by-year Capital Reinvestment Ratio for Medigene AG from 2011 to 2022. See Medigene AG (MDG1) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.08x | €11.98 Million | €1.01 Million | ▲ +42.2% |
| 2011 | 0.06x | €6.86 Million | €406.00K | — |